Verified Nov 2026
Batteries & E-Mobility
·
South San Francisco, California
·
Since 1999
Standard BioTools is a publicly traded life science tools company headquartered in South San Francisco, California, founded in 1999 and formerly known as Fluidigm Corp. It develops proteomic and multi-omic instruments, consumables, software, and laboratory services, centered on mass cytometry and microfluidics, and serves biopharma companies, academic medical centers, and government research organizations. Its employee count falls in the 500 to 1,000 range. In 2026, it agreed to sell its microfluidics business to ARCHIMED, and the transaction was completed in November 2026.
Standard BioTools at a glance
Revenue
64.8M
Employees
500-1,000
Founded
1999
Headquarters
South San Francisco, California
Ownership
Publicly traded (NASDAQ: FLDM)
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & strong
27 years in operation (founded 1999).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Standard BioTools is a publicly traded life science tools company headquartered in South San Francisco, California, founded in 1999 and formerly known as Fluidigm Corp. It develops proteomic and multi-omic instruments, consumables, software, and laboratory services, centered on mass cytometry and microfluidics, and serves biopharma companies, academic medical centers, and government research organizations. Its employee count falls in the 500 to 1,000 range. In 2026, it agreed to sell its microfluidics business to ARCHIMED, and the transaction was completed in November 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 1999 |
Headquarters | South San Francisco, California |
Employees | 500-1,000 |
Revenue | 64.8M |
Ownership | Publicly traded (NASDAQ: FLDM) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What Standard BioTools makes
The company's product portfolio includes mass cytometry systems for flow cytometry and tissue analysis, microfluidic genomic instruments, and assays and consumables for genomic applications, and it holds ISO 13485 certification.
Products and capabilities described on the company's own site include LED (source: standardbio.com).
Certifications
Standard BioTools is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — standardbio.com
Latest developments
2026-11-03 — ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific | Standard BioTools Inc. (standardbio.com)
2026-10-05 — Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED | Standard BioTools Inc. (standardbio.com)
2026-09-30 — Standard BioTools Provides Update on Sale of Mass Cytometry Business | Standard BioTools Inc. (standardbio.com)
2026-07-28 — Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences | Standard BioTools Inc. (standardbio.com)
2026-06-08 — Standard BioTools and Treeline Biosciences Announce Merger Agreement | Standard BioTools Inc. (standardbio.com)
2026-01-30 — Standard BioTools Completes Sale of SomaLogic to Illumina | Standard BioTools Inc. (standardbio.com)
Company details
The company is publicly traded under the ticker FLDM, reports a revenue band of 64.8M, and in 2026 announced a merger agreement with Treeline Biosciences. Standard BioTools was founded in 1999, has an estimated 500-1,000 employees, and is headquartered in South San Francisco, California. On the LightSource stability read it is rated "Established & strong": 27 years in operation (founded 1999). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Standard BioTools make?
Standard BioTools is a publicly traded life science tools company headquartered in South San Francisco, California, founded in 1999 and formerly known as Fluidigm Corp. It develops proteomic and multi-omic instruments, consumables, software, and laboratory services, centered on mass cytometry and microfluidics, and serves biopharma companies, academic medical centers, and government research organizations. Its employee count falls in the 500 to 1,000 range. In 2026, it agreed to sell its microfluidics business to ARCHIMED, and the transaction was completed in November 2026.
Where is Standard BioTools headquartered?
Standard BioTools is headquartered in South San Francisco, California (2 Tower Pl, South San Francisco, California, 94080-1806).
When was Standard BioTools founded?
Standard BioTools was founded in 1999.
How big is Standard BioTools?
Standard BioTools has an estimated 500-1,000 employees, with revenue in the 64.8M range.
Is Standard BioTools publicly traded?
Publicly traded (NASDAQ: FLDM). Public financial figures are drawn from its filings.
What certifications does Standard BioTools hold?
Standard BioTools lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.